Senti Biosciences (SNTI) Short Interest Ratio & Short Volume $2.26 +0.06 (+2.49%) Closing price 07/3/2025 03:33 PM EasternExtended Trading$2.26 0.00 (0.00%) As of 07/3/2025 04:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Senti Biosciences Short Interest DataSenti Biosciences (SNTI) has a short interest of 284,100 shares, representing 3.56% of the float (the number of shares available for trading by the public). This marks a 79.24% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.5, indicating that it would take 1.5 days of the average trading volume of 653,933 shares to cover all short positions.Current Short Interest284,100 sharesPrevious Short Interest158,500 sharesChange Vs. Previous Month+79.24%Dollar Volume Sold Short$738.66 thousandShort Interest Ratio1.5 Days to CoverLast Record DateJune 15, 2025Outstanding Shares26,081,000 sharesFloat Size7,970,000 sharesShort Percent of Float3.56%Today's Trading Volume113,805 sharesAverage Trading Volume653,933 sharesToday's Volume Vs. Average17% Short Selling Senti Biosciences? Sign up to receive the latest short interest report for Senti Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSNTI Short Interest Over TimeSNTI Days to Cover Over TimeSNTI Percentage of Float Shorted Over Time Senti Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2025284,100 shares $738.66 thousand +79.2%3.6%1.5 $2.60 5/31/2025158,500 shares $485.01 thousand +1.9%2.0%1.7 $3.06 5/15/2025155,600 shares $488.58 thousand -38.1%2.0%1.7 $3.14 4/30/2025251,400 shares $834.65 thousand +261.7%3.2%2.7 $3.32 4/15/202569,500 shares $255.07 thousand +13.0%0.9%2.2 $3.67 3/31/202561,500 shares $206.64 thousand +55.3%0.8%1.4 $3.36 3/15/202539,600 shares $138.20 thousand -43.8%0.4%0.6 $3.49 2/28/202570,400 shares $211.90 thousand +2.6%2.2%0.5 $3.01 2/15/202568,600 shares $299.10 thousand -33.9%2.2%0 $4.36 1/31/2025103,800 shares $452.57 thousand +95.5%3.4%0 $4.36 Get the Latest News and Ratings for SNTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Senti Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/202553,100 shares $202.31 thousand -16.5%1.8%0 $3.81 12/31/202463,600 shares $223.24 thousand -38.8%2.2%0 $3.51 12/15/2024103,900 shares $578.72 thousand +76.1%3.6%0 $5.57 11/30/202459,000 shares $127.44 thousand +1.7%2.1%0 $2.16 11/15/202458,000 shares $124.70 thousand -10.9%2.0%3.2 $2.15 10/31/202465,100 shares $141.27 thousand +10.0%2.3%2.5 $2.17 10/15/202459,200 shares $120.48 thousand -14.7%2.1%1.4 $2.04 9/30/202469,400 shares $156.84 thousand -0.7%2.4%1.4 $2.26 9/15/202469,900 shares $214.59 thousand -9.5%2.4%0.1 $3.07 8/31/202477,200 shares $204.58 thousand -30.9%2.7%0.1 $2.65 8/15/2024111,700 shares $255.79 thousand +86.2%4.0%0.2 $2.29 7/31/202460,000 shares $138.60 thousand +38.9%2.2%0.1 $2.31 7/15/202443,200 shares $136.04 thousand -70.6%1.6%0.1 $3.15 6/30/20241,470,000 shares $405.72 thousand +443.0%5.3%0.2 $0.28 6/15/2024270,700 shares $66.70 thousand +8.5%1.0%0.3 $0.25 5/31/2024249,500 shares $74.85 thousand -11.3%0.9%2 $0.30 5/15/2024281,400 shares $106.37 thousand -2.1%1.0%2.6 $0.38 4/30/2024287,300 shares $103.43 thousand +73.9%1.1%2.5 $0.36 4/15/2024165,200 shares $49.76 thousand -22.7%0.6%2 $0.30 3/31/2024213,800 shares $80.62 thousand -4.2%0.8%2.1 $0.38 3/15/2024223,200 shares $83.25 thousand -17.3%0.8%0.3 $0.37 2/29/2024269,900 shares $116.06 thousand -21.9%1.0%0.4 $0.43 2/15/2024345,400 shares $146.80 thousand +15.1%1.3%0.5 $0.43 1/31/2024300,000 shares $135.03 thousand -30.4%1.2%0.1 $0.45 1/15/2024430,700 shares $232.15 thousand -44.1%1.6%0.2 $0.54 12/31/2023769,900 shares $508.13 thousand +60.8%2.9%0.3 $0.66 12/15/2023478,900 shares $182.99 thousand -42.6%1.8%0.2 $0.38 11/30/2023834,000 shares $358.70 thousand -44.4%3.2%0.3 $0.43 11/15/20231,500,000 shares $557.70 thousand +260.1%5.7%0.6 $0.37 10/31/2023416,500 shares $116.54 thousand -8.2%1.6%0.2 $0.28Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad)Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.We recently interviewed Rickards to get the full story and understand how everyday Americans can pre 10/15/2023453,800 shares $137.00 thousand +100.6%1.7%1.6 $0.30 9/30/2023226,200 shares $93.42 thousand +7.2%0.9%0.9 $0.41 9/15/2023211,000 shares $122.82 thousand -32.7%0.8%2.9 $0.58 8/31/2023313,400 shares $203.71 thousand -6.8%1.5%4.6 $0.65 8/15/2023336,300 shares $242.47 thousand -10.1%1.6%4.8 $0.72 7/31/2023374,200 shares $322.56 thousand -12.3%1.9%5.3 $0.86 7/15/2023426,500 shares $298.55 thousand +24.9%2.1%4.4 $0.70 6/30/2023341,400 shares $214.06 thousand -15.1%1.4%3.5 $0.63 6/15/2023402,300 shares $402.30 thousand -12.8%1.6%4.6 $1.00 5/31/2023461,100 shares $407.57 thousand -11.0%1.8%5.3 $0.88 5/15/2023517,900 shares $502.36 thousand +2.9%2.0%5.8 $0.97 4/30/2023503,500 shares $493.43 thousand -0.5%1.9%5.4 $0.98 4/15/2023506,100 shares $541.53 thousand +0.2%2.0%4.9 $1.07 3/31/2023505,200 shares $596.14 thousand -9.0%2.0%5.3 $1.18 3/15/2023555,200 shares $705.10 thousand +12.6%2.2%5.4 $1.27 2/28/2023493,100 shares $739.65 thousand -4.4%1.9%2.7 $1.50 2/15/2023515,500 shares $860.89 thousand -13.1%2.0%2.8 $1.67 1/31/2023593,300 shares $1.09 million -5.1%1.7%2.8 $1.83 1/15/2023625,100 shares $1.18 million +1.6%1.8%2.4 $1.89 12/30/2022615,500 shares $867.86 thousand +65.6%1.8%0.9 $1.41 12/15/2022371,800 shares $565.14 thousand -12.3%1.1%0.1 $1.52 11/30/2022423,900 shares $974.97 thousand -6.8%1.2%0.1 $2.30 11/15/2022454,700 shares $1.10 million -12.0%1.3%0.1 $2.43 10/31/2022516,900 shares $1.20 million -20.1%1.5%0.1 $2.32 10/15/2022646,600 shares $2.11 million -1.8%1.9%0.1 $3.27 9/30/2022658,400 shares $1.43 million +265.6%1.9%0.1 $2.17 9/15/2022180,100 shares $405.23 thousand -23.0%0.5%0.1 $2.25 8/31/2022234,000 shares $458.64 thousand -16.1%0.7%0.2 $1.96 8/15/2022278,800 shares $568.75 thousand -3.5%0.8%0.2 $2.04 7/31/2022288,900 shares $904.26 thousand +110.1%0.9%0.2 $3.13 7/15/2022137,500 shares $247.50 thousand No Change0.4%0.4 $1.80 SNTI Short Interest - Frequently Asked Questions What is Senti Biosciences' current short interest? Short interest is the volume of Senti Biosciences shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 284,100 shares of SNTI short. 3.56% of Senti Biosciences' shares are currently sold short. Learn More on Senti Biosciences' current short interest. What is a good short interest ratio for Senti Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNTI shares currently have a short interest ratio of 2.0. Learn More on Senti Biosciences's short interest ratio. What is a good short interest percentage for Senti Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.56% of Senti Biosciences' floating shares are currently sold short. Is Senti Biosciences' short interest increasing or decreasing? Senti Biosciences saw a increase in short interest in June. As of June 15th, there was short interest totaling 284,100 shares, an increase of 79.2% from the previous total of 158,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Senti Biosciences' float size? Senti Biosciences currently has issued a total of 26,081,000 shares. Some of Senti Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Senti Biosciences currently has a public float of 7,970,000 shares. How does Senti Biosciences' short interest compare to its competitors? 3.56% of Senti Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Senti Biosciences: Canopy Growth Corporation (9.85%), ProQR Therapeutics N.V. (0.67%), Nanobiotix S.A. Sponsored ADR (0.02%), Y-mAbs Therapeutics, Inc. (7.79%), I-Mab Sponsored ADR (0.60%), Cardiff Oncology, Inc. (28.16%), Inhibrx Biosciences, Inc. (7.93%), MediWound Ltd. (12.32%), SOPHiA GENETICS SA (0.04%), Monopar Therapeutics Inc. (0.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Senti Biosciences stock? Short selling SNTI is an investing strategy that aims to generate trading profit from Senti Biosciences as its price is falling. SNTI shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Senti Biosciences? A short squeeze for Senti Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SNTI, which in turn drives the price of the stock up even further. How often is Senti Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNTI, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Canopy Growth Short Interest ProQR Therapeutics Short Interest Nanobiotix Short Interest Y-mAbs Therapeutics Short Interest I-Mab Short Interest Cardiff Oncology Short Interest Inhibrx Biosciences Short Interest MediWound Short Interest SOPHiA GENETICS Short Interest Monopar Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNTI) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senti Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
